Antimalarial and Plasmodium falciparum serpentine receptor 12 targeting effect of a purinergic receptor antagonist FDA approved drug
S. Gupta, N. Joshi, M. Saini, S. Singh
This study evaluates the antimalarial effect of Prasugrel, an FDA-approved purinergic receptor antagonist, on Plasmodium falciparum by targeting PfSR12, a putative purinergic receptor.
bioRxiv · Dec 16, 2020 · PreprintMicrobiology